[Treatment of malignant pleural effusion].
A malignant pleural effusion in the patients with cancer is one of the common complications that make the patients critically ill condition without the adequate treatment. The present paper reviewed the literature concerning the clinical results of all techniques designed to treat this problem. We would like to recommend intrapleural administration of several sclerosing agents with tube thoracostomy as the technique of choice. We also showed the results obtained in our hospital using intra pleural IL-2 instillation.
Takada
M
M
2nd Dept. of Internal Medicine, Osaka Prefectural Habikino Hospital.
Fukuoka
M
M
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D004317:Doxorubicin / Q000008:administration & dosage; D006801:Humans; D007322:Instillation, Drug; D007376:Interleukin-2 / Q000008:administration & dosage / Q000627:therapeutic use; D007440:Intubation; D016685:Mitomycin; D008937:Mitomycins / Q000008:administration & dosage; D009369:Neoplasms / Q000150:complications*; D010994:Pleura; D010996:Pleural Effusion / Q000209:etiology / Q000628:therapy*; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000627:therapeutic use; D012597:Sclerosing Solutions / Q000008:administration & dosage / Q000627:therapeutic use; D013907:Thoracostomy
D007376:Interleukin-2; D008937:Mitomycins; D011994:Recombinant Proteins; D012597:Sclerosing Solutions; D016685:Mitomycin; D004317:Doxorubicin